AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "S"
Results 31 - 40 of 1023 shown below |
|
|
|
|
|
|
|
| Sakahara, Harumi |
|
| Kiyokazu Takebayashi, Yoshimoto Sekine, Nori Takei, Yoshio Minabe, Haruo Isoda, Hiroyasu Takeda, Katsuhiko Nishimura, Kazuhiko Nakamura, Katsuaki Suzuki, Yasuhide Iwata, Harumi Sakahara and Norio Mori Metabolite Alterations in Basal Ganglia Associated with Psychiatric Symptoms of Abstinent Toluene Users: A Proton MRS Study doi:10.1038/sj.npp.1300426 Neuropsychopharmacology 29, 1019-1026 | Abstract | Full text | PDF | |
|
|
|
| Yoshimoto Sekine, Yoshio Minabe, Masayoshi Kawai, Katsuaki Suzuki, Masaomi Iyo, Haruo Isoda, Harumi Sakahara, Charles R Ashby, Nori Takei and Norio Mori Metabolite Alterations in Basal Ganglia Associated with Methamphetamine-related Psychiatric Symptoms: A Proton MRS Study doi:10.1016/S0893-133X(02)00321-4 Neuropsychopharmacology 27, 453-461 | Abstract | Full text | PDF | |
|
|
|
| Sakai, Kazuo |
|
| Xue-Min Gao, Kazuo Sakai and Carol A Tamminga Chronic Olanzapine or Sertindole Treatment Results in Reduced Oral Chewing Movements in Rats Compared to Haloperidol doi:10.1016/S0893-133X(98)00039-6 Neuropsychopharmacology 19, 428-433 | Abstract | Full text | PDF | |
|
|
|
| Sakamoto, Kaoru |
|
| Tetsuo Ohnishi, Tetsuo Ohnishi, Kazuo Yamada, Kazuo Yamada, Hisako Ohba, Hisako Ohba, Yoshimi Iwayama, Yoshimi Iwayama, Tomoko Toyota, Tomoko Toyota, Eiji Hattori, Eiji Hattori, Toshiya Inada, Toshiya Inada, Hiroshi Kunugi, Hiroshi Kunugi, Masahiko Tatsumi, Masahiko Tatsumi, Norio Ozaki, Norio Ozaki, Nakao Iwata, Nakao Iwata, Kaoru Sakamoto, Kaoru Sakamoto, Yoshimi Iijima, Yoshimi Iijima, Yasuhide Iwata, Yasuhide Iwata, Kenji J Tsuchiya, Kenji J Tsuchiya, Genichi Sugihara, Genichi Sugihara, Shinichiro Nanko, Shinichiro Nanko, Noriko Osumi, Noriko Osumi, Sevilla D Detera-Wadleigh, Sevilla D Detera-Wadleigh, Tadafumi Kato, Tadafumi Kato, Takeo Yoshikawa and Takeo Yoshikawa A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription doi:10.1038/sj.npp.1301307 Neuropsychopharmacology 32, 1727-1737 | Abstract | Full text | PDF | |
|
|
|
| Tetsuo Ohnishi, Tetsuo Ohnishi, Kazuo Yamada, Kazuo Yamada, Hisako Ohba, Hisako Ohba, Yoshimi Iwayama, Yoshimi Iwayama, Tomoko Toyota, Tomoko Toyota, Eiji Hattori, Eiji Hattori, Toshiya Inada, Toshiya Inada, Hiroshi Kunugi, Hiroshi Kunugi, Masahiko Tatsumi, Masahiko Tatsumi, Norio Ozaki, Norio Ozaki, Nakao Iwata, Nakao Iwata, Kaoru Sakamoto, Kaoru Sakamoto, Yoshimi Iijima, Yoshimi Iijima, Yasuhide Iwata, Yasuhide Iwata, Kenji J Tsuchiya, Kenji J Tsuchiya, Genichi Sugihara, Genichi Sugihara, Shinichiro Nanko, Shinichiro Nanko, Noriko Osumi, Noriko Osumi, Sevilla D Detera-Wadleigh, Sevilla D Detera-Wadleigh, Tadafumi Kato, Tadafumi Kato, Takeo Yoshikawa and Takeo Yoshikawa A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription doi:10.1038/sj.npp.1301307 Neuropsychopharmacology 32, 1727-1737 | Abstract | Full text | PDF | |
|
|
|
| Sakata, Mie |
|
| Mie Sakata, Hiroyoshi Sei, Naomi Eguchi, Yusuke Morita and Yoshihiro Urade Arterial Pressure and Heart Rate Increase during REM Sleep in Adenosine A2A-Receptor Knockout Mice, but not in Wild-Type Mice doi:10.1038/sj.npp.1300727 Neuropsychopharmacology 30, 1856-1860 | Abstract | Full text | PDF | |
|
|
|
| Sakoori, Kazuto |
|
| Kazuto Sakoori and Niall P Murphy Endogenous Nociceptin (Orphanin FQ) Suppresses Basal Hedonic State and Acute Reward Responses to Methamphetamine and Ethanol, but Facilitates Chronic Responses doi:10.1038/sj.npp.1301459 Neuropsychopharmacology 33, 877-891 | Abstract | Full text | PDF | |
|
|
|
| Saksida, Lisa M |
|
| Rose-Marie Karlsson, Kohichi Tanaka, Lisa M Saksida, Timothy J Bussey, Markus Heilig and Andrew Holmes Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia doi:10.1038/npp.2008.215 Neuropsychopharmacology 34, 1578-1589 | Abstract | Full text | PDF | |
|
|
|
| Sakuma, Mio |
|
| Toshiki Himeda, Natsumi Hayakawa, Hiroko Tounai, Mio Sakuma, Hiroyuki Kato and Tsutomu Araki Alterations of Interneurons of the Gerbil Hippocampus after Transient Cerebral Ischemia: Effect of Pitavastatin doi:10.1038/sj.npp.1300798 Neuropsychopharmacology 30, 2014-2025 | Abstract | Full text | PDF | |
|
|
|
| Sakurai, Takeshi |
|
| Hiroki Ishiguro, Qing-Rong Liu, Jian-Ping Gong, Frank Scott Hall, Hiroshi Ujike, Marisela Morales, Takeshi Sakurai, Martin Grumet and George R Uhl NrCAM in Addiction Vulnerability: Positional Cloning, Drug-Regulation, Haplotype-Specific Expression, and Altered Drug Reward in Knockout Mice doi:10.1038/sj.npp.1300855 Neuropsychopharmacology 31, 572-584 | Abstract | Full text | PDF | |
|
|
|
| Sala, Mariaelvina |
|
| Tiziana Rubino, Mariaelvina Sala, Daniela Viganò, Daniela Braida, Chiara Castiglioni, Valeria Limonta, Cinzia Guidali, Natalia Realini and Daniela Parolaro Cellular Mechanisms Underlying the Anxiolytic Effect of Low Doses of Peripheral  9-Tetrahydrocannabinol in Ratsdoi:10.1038/sj.npp.1301330 Neuropsychopharmacology 32, 2036-2045 | Abstract | Full text | PDF | |
|
|
|
| Tiziana Rubino, Daniela Vigano', Natalia Realini, Cinzia Guidali, Daniela Braida, Valeria Capurro, Chiara Castiglioni, Francesca Cherubino, Patrizia Romualdi, Sanzio Candeletti, Mariaelvina Sala and Daniela Parolaro Chronic 9-Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the Emotional Profile in Adult Rats: Behavioral and Biochemical Correlatesdoi:10.1038/sj.npp.1301664 Neuropsychopharmacology 33, 2760-2771 | Abstract | Full text | PDF | |
|
|
|
| Salah-Uddin, Hasib |
|
| Hasib Salah-Uddin, Elizabeth Scarr, Geoffrey Pavey, Kriss Harris, Jim J Hagan, Brian Dean, R A John Challiss and Jeannette M Watson Altered M1 Muscarinic Acetylcholine Receptor (CHRM1)-G  q/11 Coupling in a Schizophrenia Endophenotypedoi:10.1038/npp.2009.41 Neuropsychopharmacology 34, 2156-2166 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
